BHVNNYSEPharmaceutical PreparationsFiscal year ends December 31
Biohaven Ltd.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$11.35+0.57 (+5.29%)
Close on Oct 19, 2026
- Market cap
- $1.71B
- P/E (TTM)
- –
- Dividend yield
- –
Biohaven statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Biohaven | Industry median |
|---|---|---|
| Market Cap | $1.71B | $166.30M |
| Enterprise Value | $1.71B | $88.19M |
| PB Ratio | 140.27 | 2.03 |
Income (trailing twelve months)
| Measure | Biohaven | Industry median |
|---|---|---|
| Operating Income | -$567.44M | -$21.40M |
| Pretax Income | -$585.61M | -$14.34M |
| Net Income | -$586.84M | -$22.46M |
| EBITDA | -$557.12M | -$16.91M |
| EPS (Diluted) | -$4.64 | -$0.83 |
Returns
| Measure | Biohaven | Industry median |
|---|---|---|
| Return on Equity (ROE) | -799.5% | -53.2% |
| Return on Assets (ROA) | -127.4% | -40.9% |
| Return on Capital Employed (ROCE) | -184.2% | -38.1% |
Balance sheet
| Measure | Biohaven | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $267.87M | $61.43M |
| Total Debt | $259.48M | $118.52M |
| Net Cash (Debt) | $8.39M | $15.35M |
| Net Cash Per Share | $0.06 | $0.66 |
| Equity (Book Value) | $12.22M | $49.09M |
| Book Value Per Share | $0.08 | $1.37 |
| Tangible Book Value | -$7.57M | $23.52M |
| Working Capital | $233.90M | $76.81M |
Financial position
| Measure | Biohaven | Industry median |
|---|---|---|
| Current Ratio | 4.73 | 3.34 |
| Quick Ratio | 4.28 | 2.44 |
| Debt / Equity | 21.23 | 0.52 |
Cash flow (trailing twelve months)
| Measure | Biohaven | Industry median |
|---|---|---|
| Operating Cash Flow | -$511.40M | -$12.35M |
| Capital Expenditures | -$475.00K | -$1.08M |
| Free Cash Flow | -$511.87M | -$20.22M |
| FCF Per Share | -$3.39 | -$0.42 |
Efficiency
| Measure | Biohaven | Industry median |
|---|---|---|
| Profits Per Employee | -$2.14M | -$703.34K |
| Employee Count | 274 | 74 |
Dividends and yields
| Measure | Biohaven | Industry median |
|---|---|---|
| Earnings Yield | -34.2% | -23.3% |
| FCF Yield | -29.9% | -8.72% |
| Buyback Yield | -21.5% | -0.59% |
| Shareholder Yield | -21.5% | 0.00% |
Shares
| Measure | Biohaven | Industry median |
|---|---|---|
| Shares Outstanding | 151,044,000 | 58,127,000 |
| Shares Change (YoY) | 31.2% | 10.9% |
| Shares Change (QoQ) | 0.34% | 0.54% |
| Float | 130,074,000 | 49,136,700 |
| Shares Held by Insiders | 13.9% | 11.6% |
| Shares Held by Institutions | 93.4% | 59.4% |
Taxes
| Measure | Biohaven | Industry median |
|---|---|---|
| Income Tax | $1.24M | $79.87K |
Scores
| Measure | Biohaven | Industry median |
|---|---|---|
| Altman Z-Score | -10.31 | -0.22 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from Biohaven's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.